Intravenous Solutions Market to Show 6.5% CAGR to 2022, States IMARC Group in In-demand Report Now Available at MarketPublishers.com
11 Jan 2018 • by Natalie Aster
LONDON – Worldwide, the intravenous solutions market reached over USD 7 billion by value by end-2016. The market is expected to be estimated at nearly USD 11 billion by 2022, demonstrating a 6.5% CAGR in the coming years.
The hike in the prevalence rate of diseases, like GI disorders, neurological abnormalities, ontological diseases and diabetes, owing to unhealthy dietary habits acts as the major factor stimulating the growth of the market for intravenous solutions. Furthermore, as these solutions exist in portable packages, it gets easier for the patients to use the drips at home rather than in a hospital setting. In addition, developing economies, like India and China, are investing more into the healthcare sector which is poised to enhance the demand for intravenous solutions. Further, producers are developing novel product innovations, such as launching premixed solutions for improved convenience and to curtail the amount of commercial waste.
Geography-wise, the North America region captures the better half of the total sales, with Europe and APAC following after.
B. Braun Melsungen, Ajinomoto, Otsuka Pharmaceutical, Baxter International Inc., and Grifols, amid others, are the outstanding players in the market.
In-demand research report “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” elaborated by IMARC Group offers an all-round, unprejudiced analysis and forecast of the marketplace on a global level, covering all the essential aspects.
The publication categorises the market based on segmented the market on the basis of type, nutrient, and by region. It gives a macro overview of the industry as well as delves into micro details of the sector’s performance, keeps track of the latest trends, canvasses key market driving factors and challenges, includes a granular SWOT analysis, includes Porter’s five forces analysis and an analysis of the various stages in the value chain, etc. A detailed assessment of the manufacturing process is also available in the study. The research report examines the market structure, gives an assessment of the degree of competition in the world intravenous solutions marketplace, and includes exhaustive profiles of the 5 leading market players.
More in-demand research reports by this publisher can be found at IMARC Group page.